Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Surg Oncol. 2018 May 5;27(2):266–274. doi: 10.1016/j.suronc.2018.05.001

Table 2.

This table outlines the current clinical trials that are underway looking at effects of different drugs and anesthetics agents on patients undergoing breast cancer surgery.

Trial Number Study Question Interventions
NCT01204242 Does IV lidocaine have an effect on recovery and recurrence Placebo vs Lidocaine
NCT02089178 Do TIVA vs Inhaled affect cancer cell cytotoxicity, micrometastasis, and recurrence Propofol-remifentanil vs sevoflurane-remifentanil
NCT02449954 What are the effects of morphine, ketorolac, and tramadol on postoperative stress and immune response IV morphine sulphate vs IV tramadol HCL vs IV ketorolac
NCT02839668 Does IV anesthesia affect angiogenesis Different combinations of: IV lidocaine, sevoflurane, TIVA-TCI, acetaminophen, tramadol, neostigmine, atropine
NCT00418457 Does regional anesthesia affect recurrence General anesthesia and opioids vs regional analgesia and propofol
NCT03005860 Does propofol vs sevoflurane affect serum biomarkers and PBMCs 2,6-Diisopropylphenol vs fluoromethyl hexafluoroisopropyl ether
NCT01806259 Does ketorolac affect RFS Ketorolac vs active placebo
NCT02141139 NSAIDS and DFS No drug or acetaminophen vs NSAIDS (ketorolac and ibuprofen)
NCT01692210 Does dexmedetomidine change immune parameters Dexmedetomidine
NCT00418457 Does regional anesthesia affect breast cancer recurrence General anesthesia and opioid vs regional analgesia and propofol